Ballicules.com

Amphetamine XR-ODT

ADZENYS XR-ODT

What it isExtended-release amphetamine (ADZENYS XR-ODT, 2016) that releases norepinephrine, dopamine, and serotonin; ADHD.

Why this oneThe orally disintegrating tablet needs no water and uses 50% IR / 50% ER; 3.1 mg = 5 mg mixed salts, with 8-12 h (Carlat Table 1) of action.

What limits itAppetite loss, insomnia, cardiovascular stimulation, and abuse risk remain those of amphetamine.

FDA-approved for

FDA label

BOXED WARNING High potential for abuse, misuse, and addiction; can lead to overdose and death.
FDA dosingPopulationStartTargetMax
ADHDAdults12.5 mg QAM
ADHDPeds 6–12 yr6.3 mg QAM; titrate 3.1–6.3 mg/wk18.8 mg/day
ADHDPeds 13–17 yr6.3 mg QAM; titrate 3.1–6.3 mg/wk12.5 mg/day

Titration Titrate at weekly intervals

Renal Undefined

Hepatic Undefined

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy May cause premature delivery and low birth weight; monitor neonates for withdrawal.

Lactation Breastfeeding not recommended (amphetamine present in milk).

⚠ BOXED WARNING

Classes and tags

Clinical profile

Direct muscarinic antagonism0 / 4

Mechanism of action: Amphetamine XR-ODT ballicule

Amphetamine XR-ODT ballicule: receptor binding, kinetics and half-life diagram

Open Amphetamine XR-ODT in the interactive console ↗

Memory aids: mascots and interaction avatars

Amphetamine XR-ODT Adzenys XR-ODT mascot mnemonic cartoon
“Zen Amp”
Amphetamine XR-ODT weak base avatar
weak base

Open Amphetamine XR-ODT in the interactive console ↗